White label ELPA - ClinicalTrials.eu

Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Not recruiting

3 1
Investigated Diseases:
- Chronic rhinosinusitis with nasal polyps
Investigated Drugs:
- Itepekimab
+5
Study of Ivonescimab for Treating Relapsed Pleural Mesothelioma in Patients After Immunotherapy and Chemotherapy

Not recruiting

2 1 1
Investigated Drugs:
- Ivonescimab
Study on Itepekimab for Adults with Chronic Rhinosinusitis and Nasal Polyps

Not recruiting

3 1
Investigated Diseases:
- Chronic rhinosinusitis with nasal polyps
Investigated Drugs:
- Itepekimab
+4
Study on the Long-term Safety of Batoclimab for Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Not recruiting

2 1 1
Investigated Diseases:
- Chronic inflammatory demyelinating polyradiculoneuropathy
Investigated Drugs:
- Batoclimab
+4
Study on the Effect of Adrenaline, Vasopressin, and Steroids on Survival in Cardiac Arrest Patients

Not recruiting

3 1 1 1
Investigated Drugs:
Study of CVN424 for Reducing Motor Complications in Parkinson’s Disease Patients

Not recruiting

2 1
Investigated Drugs:
- 1-[2-[4-(2,4-DIFLUOROPHENOXY)PIPERIDIN-1-YL]-3-[[(3R)-OXOLAN-3-YL]AMINO]-7,8-DIHYDRO-5H-PYRIDO[3,4-B]PYRAZIN-6-YL]ETHANONE
Study on the Safety and Effects of ALN-APP for Patients with Cerebral Amyloid Angiopathy

Not recruiting

2 1
Investigated Diseases:
- Cerebral amyloid angiopathy
Investigated Drugs:
- ALN-961583
Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Raludotatug Deruxtecan
Study of Momelotinib and Luspatercept for Patients with Transfusion-Dependent Myelofibrosis

Not recruiting

2 1 1 1
Investigated Diseases:
- Primary myelofibrosis
Investigated Drugs:
- Momelotinib Dihydrochloride Monohydrate
- Luspatercept
Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren’s Syndrome

Not recruiting

3 1 1
Investigated Diseases:
- Sjogren’s syndrome
Investigated Drugs:
- Efgartigimod Alfa
+12

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies